Tirzepatide has something retatrutide lacks: millions of real patients, which means real before-and-afters exist. It also means an ocean of marketing photos with no provenance. The trustworthy version of 'before and after' is the trial record plus the withdrawal data, and it tells a more useful story than any photo pair.
The trial numbers
| Measure | Result (SURMOUNT-1, 72 weeks) |
|---|---|
| Mean loss, 15 mg arm | -20.9% of body weight |
| Mean loss, placebo | -3.1% |
| Lost 20% or more (15 mg) | More than half of participants |
| Lost 25% or more (15 mg) | Roughly a third |
The spread matters as much as the mean: some participants lost over a third of their body weight; a minority responded weakly. Any single photo pair you see sits somewhere unknown on that distribution, which is precisely why photos inform less than they persuade.
The timeline patients actually experience
- Weeks 1 to 4 (2.5 mg): appetite quiets before the scale moves much; nausea, if any, shows early.
- Months 2 to 4: escalation through 5 to 10 mg; the steepest visible change for most people.
- Months 5 to 12: continued loss at maintenance dose, slowing gradually.
- Months 12 to 18: approach to plateau; SURMOUNT curves flatten near 60 to 72 weeks. The 'after' photo has a natural date.
The part photos never show: stopping
The withdrawal arm of SURMOUNT-4 is the most important before-and-after in the program: participants switched to placebo regained most of their lost weight within a year, while those continuing kept losing. Whatever the photos show at month 12, the month-24 picture is decided by whether treatment (or serious maintenance work) continues. A before-and-after without a 'what happened next' is half a result.
Reading transformation photos skeptically
- Provenance: clinic-owned photos are advertising; patient-posted photos with dated timelines (Reddit's GLP-1 communities) are the closest thing to raw data.
- Composition: posture, lighting, and clothing account for several visual 'percent'; DEXA numbers don't pose.
- Muscle: the gaunt version of a 20% loss and the trained version photograph very differently; the drug doesn't choose which one you get, training does.
- Compounded-product photos prove nothing about the vial you would receive; only the branded pens are a consistent product.
Frequently asked questions
How much weight can you lose on tirzepatide in 3 months?
Trial curves show roughly 8 to 12% of body weight by month 3 at escalating doses, with wide individual spread. Three months is mid-escalation: the headline 20% figures come from 72-week data, not a quarter.
Do you gain the weight back after tirzepatide?
SURMOUNT-4's answer: most of it, within a year, if treatment stops and nothing replaces it. Continuation or a serious maintenance protocol is part of any honest plan.
Are tirzepatide before-and-after photos real?
Many are, because real patients exist at scale, and many are marketing with no provenance. Trust dated, self-posted timelines over clinic galleries, and trust the trial distributions over both.